| Biologic Therapy |
1 |
1 |
| Cancer |
0 |
0.68 |
| Non-Hodgkin Lymphoma (NHL) |
0 |
0.65 |
| Toxicology |
0 |
0.57 |
| CAR-T |
0 |
0.51 |
| Diffuse Large B-Cell Lymphoma |
0 |
0.48 |
| Follicular Lymphoma |
0 |
0.42 |
| Grant |
0 |
0.41 |
| Lymphoma |
0 |
0.41 |
| B-Cell Lymphoma |
0 |
0.39 |
| Healthcare and Medical Technology |
0 |
0.15 |
| Antigens |
0 |
0.14 |
| Clinical Research |
0 |
0.14 |
| Food and Drug Administration (FDA) |
0 |
0.14 |
| Pennsylvania |
0 |
0.14 |
| Receptors |
0 |
0.14 |